Member Info for RustyJames

Said the same at Hvivo and sold everything..

Friel is a used car salesman type, alot of what he says is fabricated..

Thats all BS!

Cathal Friel's business philosophy 'is a bird in the hand is worth 2 in the bush'..

He has no interest in going thru the FDA process..

But I do know Cathal Friel..He'll sell with milestone payment.That's his way of derisking!!

Obviously if Polb-001 works..

Its common knowledge here in Ireland that Jeremy Skillington was the architect behind the acquisitions by Roche..

And Cathal Friel will bite the hand off the highest bidder..He does not want to be involved in lengthy FDA,EMA trials..

Anyhow right now its all speculation but what going on now remind me of what happened at Inflazome,the acquisition happened when the results of the trial were announced.

Luke O Neill is playing a bigger role behind the scenes,even though his title is an advisor..

and Jeremy's role was alot bigger than you say..

Jeremy Skillington was instrumental in executing the acquisition by leading the business development strategy and deal negotiations.His Strategic Role in the DealLaying the Groundwork: Skillington initiated and managed the discussions with Roche and several other global pharmaceutical suitors over the course of a year.Creating Competition: He built a competitive bidding environment that culminated in multiple concurrent offers on the table before finalizing the deal with Roche.Leveraging Clinical Milestone Data: He timed the final transaction push to coincide with the release of critical Phase I clinical data, which maximized the company's

He management have a history of selling early.

Inflazome was acquired for €380 million upfront (with milestone payments) by Roche.

Maybe for someone like you who not a long term holder but some people have been here since 2020 and are underwater.

Back in the day Hvivo investors were promised the sun, moon and stars when Poolbeg was divested.

Well Poolbeg is a Hvivo spinoff...some of us here got a dividend..so yes it is of interest..

Poolbeg's market cap has now surpassed Hvivo's..

Yep there is some nibbling today..

Perhaps they gave themselves options knowing the pipeline is gearing up..

Definitely something going on Thinice..Has the trial started?

Trout..its a microcap that recently had to do a 1 for 12 reverse split to stay Nasdaq compliant..

They have 4 million in cash and 3 or that is restricted to the Gates foundation.

We'll see!!!!

If Cathal Friel gets sniff of positive data in the trial he'll sell lock stock and barrel to a J&J or the likes.

Its POLB001 or nothing!

Sorry was thinking of Traws🙄

So is this an addition the original contract.

All business is good but I wish it wasn't so vague..

Looking at Dell today added nearly $100 billion to its market cap..

Personally I think the EU and the UK is screwed..

No Vision!

Yep Theta, totally agree..bonuses should be tied into sustained growth and share price performance..I tell ya 1 thing if I was Andrew Catchpool a long term senior executive I'd be majority pizzed off at Mo and Pinkerton lining their pockets.

I'd actually say we're looking good for a move up to the next level..

Have a feeling Poolbeg Pharma market cap will surpass Hvivo's in the coming weeks..

The offspring outshines the parent at least for the short/medium term.